EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudiePragmatische StudieOpen Access · CC BY 4.0

Outcomes of specialist physiotherapy for functional motor disorder: the Physio4FMD RCT

Glenn Nielsen iD, Louise Marston iD, Rachael Maree Hunter iD, Alan Carson iD, Laura H Goldstein iD, Kate Holt iD, Teresa C Lee iD, Marie Le Novere iD, Jonathan Marsden iD, Irwin Nazareth iD, Hayley Noble iD, Markus Reuber iD und 5 weitere

Health Technology Assessment · 2025

DOI: 10.3310/mkac9495 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Health Technology Assessment, 2025. Verfasst von Glenn Nielsen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience and Cell Biology Institute, St George's, University of London, London, UK. Hauptthemen laut MEDLINE: Physical Therapy Modalities. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Technology Assessment programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Functional motor disorder often causes persistent disabling symptoms that are associated with high healthcare costs. In recent years, specialist physiotherapy, informed by an understanding of functional motor disorder, has emerged as a promising treatment, but there is an absence of evidence of its effectiveness from large randomised controlled trials.

Methods

We conducted a pragmatic, multicentre, randomised controlled trial, comparing specialist physiotherapy for functional motor disorder to treatment as usual, which was defined as community neurological physiotherapy. The primary outcome was the Short Form questionnaire-36 items Physical Functioning domain at 12 months (scale range 0–100, with 100 indicating optimum health). The trial was powered to detect a 9-point difference in the primary outcome with 90% power at the 5% level of significance. Secondary domains of measurement included a patient perception of improvement, health-related quality of life, mobility, anxiety, depression and illness perception. We also completed a health economic analysis with the primary aim of calculating the mean incremental cost per quality-adjusted life-year over 12 months. In prespecified analysis plans, we excluded participants from the primary analysis if they were unable to receive their trial-allocated treatment due to COVID-19 lockdown restrictions. Sensitivity analysis explored the impact of this decision.

Results

Between 19 October 2018 and 31 January 2022, 355 adults with functional motor disorder were randomised (1 : 1) to specialist physiotherapy ( n = 179) and treatment as usual ( n = 176). Eighty-nine participants were excluded due to COVID-19 disruptions. Retention for the primary analysis was 90% for both groups, leaving 241 participants in the primary analysis. At 12 months, there was no between-group difference in the primary outcome (adjusted mean difference 3.5, 95% confidence interval −2.3 to 9.3). However, several secondary outcomes favoured specialist physiotherapy, including the participant perception of improvement, Short Form questionnaire-36 items Mental Health domain, confidence in the diagnosis and two subscales (Personal Control and Illness Coherence) of the Revised Illness Perception Questionnaire. There were no differences in the remaining outcomes. At 6 months, the following outcome measures were significantly different, in favour of specialist physiotherapy: participant perception of improvement, the Short Form questionnaire-36 items Physical Role Limitations, Short Form questionnaire-36 items Social Functioning, Short Form questionnaire-36 items Mental Health, EuroQol-5 Dimensions five-level version utility score, confidence in the diagnosis and three subscales (Timeline Cyclical, Personal Control and Treatment Control) of the Revised Illness Perception Questionnaire. No outcomes significantly favoured treatment as usual. In the health economic analysis, the incremental cost per quality-adjusted life-year gained from a health and social care cost perspective was £4133 with an 86% probability that specialist physiotherapy is cost-effective compared to treatment as usual at a cost-effectiveness threshold of £20,000 per quality-adjusted life-year gained. There were no adverse events related to physiotherapy.

Conclusion

Specialist physiotherapy was not superior to treatment as usual for the primary outcome, the Short Form questionnaire-36 items Physical Functioning domain at 12 months. However, a number of secondary outcome measures favoured specialist physiotherapy at 6 and 12 months. There is a high probability that specialist physiotherapy is cost-effective.

Limitations

Participants in treatment as usual waited longer to start physiotherapy, which resulted in a shorter time between concluding treatment and completing the primary outcome. Most outcome measures, including the primary outcome, were participant reported, which may have been biased by perceptions of the randomised treatment allocation. Future work Future work should identify or develop more suitable outcome measures for functional motor disorder research, explore who is most likely to benefit from specialist physiotherapy and identify alternative interventions for those unlikely to benefit from this treatment. Additional work is needed to adapt treatment to meet the needs of minority groups and young people. Funding This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 16/31/63.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Physical Therapy ModalitiesHumansMaleFemaleMiddle AgedQuality of LifeAdultCost-Benefit AnalysisQuality-Adjusted Life YearsCOVID-19AgedTreatment OutcomeTechnology Assessment, BiomedicalSARS-CoV-2

Stichwörter der Autor:innen

ANXIETYCLINICAL PROTOCOLSCONVERSION DISORDERFNDFUNCTIONAL MOTOR DISORDERFUNCTIONAL NEUROLOGICAL DISORDERMOTOR DISORDERSMOVEMENT DISORDERSNEUROLOGYOUTCOME ASSESSMENT HEALTH CAREPHYSICAL THERAPY MODALITIESPHYSIOTHERAPYQUALITY OF LIFERANDOMISED CONTROLLED TRIALRANDOMIZED CONTROLLED TRIALS AS TOPIC

Autor:innen und Institutionen

  • Neuroscience and Cell Biology Institute, St George's, University of London, London, UK.
  • Department of Primary Care and Population Health, University College London, London, UK.
  • PRIMENT Clinical Trials Unit, University College London, London, UK.
  • Department of Applied Health Research, University College London, London, UK.
  • Centre for Clinical Brain Sciences, Royal Infirmary of Edinburgh, Edinburgh, UK.
  • Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

ORCID-Profile: Glenn Nielsen, Louise Marston, Rachael Maree Hunter, Alan Carson, Laura H Goldstein, Kate Holt, Teresa C Lee, Marie Le Novere, Jonathan Marsden, Irwin Nazareth, Hayley Noble, Markus Reuber, Jon Stone, Ann-Marie Strudwick, Beatriz Santana Suarez, Mark J Edwards

Förderung

  • Health Technology Assessment programme

Zitieren

APA

Nielsen, G., Marston, L., Hunter, R. M., Carson, A., Goldstein, L. H., Holt, K., Lee, T. C., Le Novere, M., Marsden, J., Nazareth, I., Noble, H., Reuber, M., Stone, J., Strudwick, A. M., Suarez, B. S., Edwards, M. J., & Physio4FMD Study Group (2025). Outcomes of specialist physiotherapy for functional motor disorder: the Physio4FMD RCT. Health Technology Assessment. https://doi.org/10.3310/mkac9495

Vancouver

Nielsen G, Marston L, Hunter RM, Carson A, Goldstein LH, Holt K, et al. Outcomes of specialist physiotherapy for functional motor disorder: the Physio4FMD RCT. Health Technology Assessment. 2025. doi:10.3310/mkac9495

BibTeX
@article{Nielsen2025,
  author = {Nielsen, Glenn and Marston, Louise and Hunter, Rachael Maree and Carson, Alan and Goldstein, Laura H and Holt, Kate and Lee, Teresa C and Le Novere, Marie and Marsden, Jonathan and Nazareth, Irwin and Noble, Hayley and Reuber, Markus and Stone, Jon and Strudwick, Ann-Marie and Suarez, Beatriz Santana and Edwards, Mark J and Physio4FMD Study Group, Physio4FMD Study Group},
  title = {Outcomes of specialist physiotherapy for functional motor disorder: the Physio4FMD RCT},
  journal = {Health Technology Assessment},
  year = {2025},
  doi = {10.3310/mkac9495}
}
Kostenlos starten →